30 June 2022

Medications Political Telehealth

Phone rebate cuts hurt the most vulnerable

30 June 2022

Juvenile Arthritis Osteoporosis Spondyloarthritis

Risk from low-dose steroids challenged

30 June 2022

Research Surgical

Q&A with Associate Professor Helen Benham

30 June 2022

Complementary Rheumatoid Arthritis

Curcumin for OA: what is the evidence?

23 June 2022

Analgesics Mental Health Rheumatoid Arthritis

Mental illness leads chronic disease pack

23 June 2022

Biologics Gout PBAC

‘Game-changer’ on horizon for alopecia areata

23 June 2022

Rheumatoid Arthritis

The rise and (sort of) fall of glucosamine

16 June 2022

COVID-19 Lupus Scleroderma Spondyloarthritis

Rituximab and non-white ethnicity linked with worse covid outcomes

16 June 2022

Surgical

Q&A with Dr Claire Barrett

16 June 2022

Analgesics COVID-19

Doctors at risk of green-nail syndrome

16 June 2022

APLAR Conditions

What should an Australian CDC look like?

9 June 2022

Reactive Arthritis

Lupus hope found in psoriasis and cancer drugs

9 June 2022

NSAIDS

Trainee GP sent to wrestling camp in mix-up

9 June 2022

Diet Polymyalgia Rheumatica Spondyloarthritis

Poor evidence that diet helps arthritis and gout

6 June 2022

Reactive Arthritis

Viral and fungal infections take over as key opportunistic diseases

6 June 2022

Pharmacy Guild of Australia Spondyloarthritis

EULAR 2022 – Editor’s choice